Anxiety disorders and depression are associated with resistant hypertension
Künye
Duman, H., Duman, H., Puşuroğlu, M., & Yılmaz, A. S. (2023). Anxiety disorders and depression are associated with resistant hypertension. Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 10.17219/acem/166304. Advance online publication. https://doi.org/10.17219/acem/166304Özet
Background. Anxiety and depression can adversely affect theprognosis following cardiovascular diseases
(CVDs) and may be associated with resistance to hypertension (HT) treatment. A better understanding
of the complex biological substratum of resistant HT complicated by depression and anxiety is crucial for
designing future primary care strategies.
Objectives. Toevaluate therelationship between anxiety and depression and resistant HT, which will help
tolook at resistant HT from abroader perspective and aid thedevelopment ofnew strategies for diagnosis
and treatment.
Materials and methods. We used a stratified random sampling method to select HT patients aged18
and older inprimary care setting. A total of300consecutive patients with persistent HT who were diagnosed
with essential HT and uncontrolled blood pressure (BP) despite antihypertensive therapy were prospectively
included inthestudy. Anxiety and depression were investigated, and scoring was evaluated using the Hospital
Anxiety and Depression Scale (HADS).
Results. Thestudy included 108controlled and 91uncontrolled HT patients. The HADS scales were higher
inthecontrolled HT group compared totheuncontrolled HT group (6 (0–18) compared to9 (0–20), p=0.001;
5 (0–17) compared to7 (0–16), p<0.001, respectively). Body mass index (BMI) and C-reactive protein (CRP)
were also significantly higher intheuncontrolled HT patients compared tothenormotensive group. Anxiety
was associated with a 2.18 times increased risk of HT and a 1.99 times increased risk of depression. Thus,
anxiety and depression predicted resistant HT inboth univariate and multivariate analyses.
Conclusions. During thetreatment of HT, efforts should be made toimprove thepsychological and social
functions of thepatients beyond theprimary therapy for control of thedisease. As such, wehope todraw
attention totheimportance ofpsychological factors, especially anxiety and depression, inany field ofmedicine
related to managing resistant HT.